{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:54:21Z","timestamp":1790430861199,"version":"4.1.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T00:00:00Z","timestamp":1620172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"BHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.atherosclerosis.2021.04.021","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T21:49:22Z","timestamp":1620337762000},"page":"18-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies"],"prefix":"10.1016","volume":"327","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5445-6906","authenticated-orcid":false,"given":"Kathryn A.","family":"McGurk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard D.","family":"Keavney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1314-413X","authenticated-orcid":false,"given":"Anna","family":"Nicolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib1","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/eurheartj\/ehv236","article-title":"Novel methodologies for biomarker discovery in atherosclerosis","volume":"36","author":"Hoefer","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib2","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1007\/s00125-009-1482-9","article-title":"Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease","volume":"52","author":"De Mello","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12020-011-9589-4","article-title":"Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome","volume":"41","author":"Majumdar","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib4","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib5","first-page":"43","article-title":"Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic \u03b2 cells and adipocytes, Best Pract","volume":"28","author":"Tao","year":"2014","journal-title":"Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib7","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.8456305","article-title":"Programmed cell death induced by ceramide","volume":"259","author":"Obeid","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib8","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/01.ATV.18.10.1523","article-title":"Sphingolipids in atherosclerosis and vascular biology","volume":"18","author":"Chatterjee","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.atherosclerosis.2015.10.022","article-title":"Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study","volume":"243","author":"Cheng","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib10","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/eurheartj\/ehx146","article-title":"Regulation of oxidized platelet lipidome: implications for coronary artery disease","volume":"38","author":"Chatterjee","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/jc.2013-2559","article-title":"Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency","volume":"99","author":"Tarasov","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MCA.0000000000000079","article-title":"Elevation of ceramide and activation of secretory acid sphingomyelinase in patients with acute coronary syndromes","volume":"25","author":"Pan","year":"2014","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib13","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib14","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1007\/s00216-016-9425-z","article-title":"Development and validation of a high-throughput LC\u2013MS\/MS assay for routine measurement of molecular ceramides","volume":"408","author":"Kauhanen","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib15","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/CIRCULATIONAHA.116.024261","article-title":"Plasma ceramides, mediterranean diet, and incident cardiovascular disease in the PREDIMED trial","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/er.2007-0025","article-title":"Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism","volume":"29","author":"Holland","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib18","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1126\/science.274.5294.1855","article-title":"Functions of ceramide in coordinating cellular responses to stress","volume":"274","author":"a Hannun","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0005-2760(98)00145-3","article-title":"The role of ceramide in cell signaling","volume":"1436","author":"Perry","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib20","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1194\/jlr.D800055-JLR200","article-title":"Comprehensive quantification of ceramide species in human stratum corneum","volume":"50","author":"Masukawa","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib21","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1194\/jlr.M800014-JLR200","article-title":"Characterization of overall ceramide species in human stratum corneum","volume":"49","author":"Masukawa","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib22","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1194\/jlr.R800080-JLR200","article-title":"Bioactive sphingolipids: metabolism and function","volume":"50","author":"Bartke","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib23","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1172\/JCI57144","article-title":"Ceramides as modulators of cellular and whole-body metabolism","volume":"121","author":"Bikman","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0092-8674(95)90429-8","article-title":"Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals","volume":"82","author":"Bose","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0092-8674(94)90275-5","article-title":"Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling","volume":"78","author":"Wiegmann","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib27","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1074\/jbc.273.7.4081","article-title":"Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase","volume":"273","author":"Marathe","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.plipres.2012.10.003","article-title":"Bioactive lipid mediators in skin inflammation and immunity","volume":"52","author":"Kendall","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib30","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3398","article-title":"Ceramide-orchestrated signalling in cancer cells","volume":"13","author":"Morad","year":"2013","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10863-005-6632-2","article-title":"Sphingosine forms channels in membranes that differ greatly from those formed by ceramide","volume":"37","author":"Siskind","year":"2005","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1194\/jlr.M700480-JLR200","article-title":"Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins","volume":"49","author":"Stiban","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib34","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.bbamem.2006.08.009","article-title":"Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy","volume":"1758","author":"Zheng","year":"2006","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjp.0703407","article-title":"Apoptosis in the vasculature: mechanisms and functional importance","volume":"130","author":"Mallat","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib37","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s10495-008-0302-x","article-title":"Role of apoptosis in cardiovascular disease","volume":"14","author":"Lee","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib38","first-page":"1257","article-title":"Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion","volume":"151","author":"Bielawska","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib39","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","article-title":"Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib40","doi-asserted-by":"crossref","unstructured":"N.Y. Villa, B.R. Kupchak, I. Garitaonandia, J.L. Smith, E. Alonso, C. Alford, L.A. Cowart, Y.A. Hannun, T.J. Lyons, Sphingolipids Function as Downstream Effectors of a Fungal, (2009) 866\u2013875. doi:10.1124\/mol.108.049809.","DOI":"10.1124\/mol.108.049809"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib41","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3945\/jn.115.220459","article-title":"A healthy nordic diet alters the plasma lipidomic profile in adults with features of metabolic syndrome in a multicenter randomized dietary intervention","volume":"146","author":"Lankinen","year":"2016","journal-title":"J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib42","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2337\/db12-0363","article-title":"A lipidomics analysis of the relationship between dietary fatty acid composition and insulin sensitivity in young adults","volume":"62","author":"Kien","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.CIR.0000048890.59383.8D","article-title":"Exercise and cardiovascular health","volume":"107","author":"Myers","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib44","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00125-011-2065-0","article-title":"Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide","volume":"54","author":"Dub\u00e9","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib45","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metabol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib46","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1074\/jbc.M115.691212","article-title":"Ceramide synthase 5 is essential to maintain C16:0-Ceramide pools and contributes to the development of diet-induced obesity","volume":"291","author":"Gosejacob","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molmet.2018.12.008","article-title":"The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach","volume":"21","author":"Raichur","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib48","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41366-018-0291-y","article-title":"Maternal obesity leads to long-term altered levels of plasma ceramides in the offspring as revealed by a longitudinal lipidomic study in children","volume":"43","author":"Le\u00f3n-Aguilar","year":"2019","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib49","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib50","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/ATVBAHA.108.173344","article-title":"Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression","volume":"28","author":"Devlin","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib51","doi-asserted-by":"crossref","first-page":"823071","DOI":"10.1155\/2014\/823071","article-title":"Endogenous ceramide contributes to the transcytosis of oxldl across endothelial cells and promotes its subendothelial retention in vascular wall","volume":"2014","author":"Li","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/jpet.112.201442","article-title":"Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium","volume":"345","author":"Wei","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib53","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s11745-006-5041-6","article-title":"Association of ceramides in human plasma with risk factors of atherosclerosis","volume":"41","author":"Ichi","year":"2006","journal-title":"Lipids"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib54","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1210\/jc.2014-4348","article-title":"Association of plasma ceramides and sphingomyelin with VLDL apoB-100 fractional catabolic rate before and after rosuvastatin treatment","volume":"100","author":"Ng","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib55","doi-asserted-by":"crossref","first-page":"27855","DOI":"10.1074\/jbc.R111.254359","article-title":"Many ceramides","volume":"286","author":"Hannun","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib56","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/acel.12369","article-title":"Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species","volume":"14","author":"Mielke","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.18632\/aging.101719","article-title":"Elevated plasma ceramide levels in post-menopausal women: a cross-sectional study","volume":"11","author":"Vozella","year":"2019","journal-title":"Aging (Albany. NY)"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2018.12.046","article-title":"Circulating sphingolipids, fasting glucose, and impaired fasting glucose: the Strong Heart Family Study","volume":"41","author":"Jensen","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0047-6374(00)00191-3","article-title":"Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging","volume":"120","author":"Lightle","year":"2000","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib60","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1248\/bpb.b13-00180","article-title":"Increase in secretory sphingomyelinase activity and specific ceramides in the aorta of apolipoprotein E knockout mice during aging","volume":"36","author":"Kobayashi","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib61","first-page":"1","article-title":"Age-related remodeling of small arteries is accompanied by increased sphingomyelinase activity and accumulation of long-chain ceramides","volume":"2","author":"Ohanian","year":"2014","journal-title":"Phys. Rep."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib62","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.0705049104","article-title":"Ceramide transfer protein function is essential for normal oxidative stress response and lifespan","volume":"104","author":"Rao","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib63","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1096\/fj.07-8621com","article-title":"Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1","volume":"21","author":"Wooten-Blanks","year":"2007","journal-title":"Faseb. J."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib64","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1474-9726.2006.00232.x","article-title":"Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A","volume":"5","author":"Smith","year":"2006","journal-title":"Aging Cell"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/HYPERTENSIONAHA.113.01396","article-title":"Plasma lipidomic profile signature of hypertension in mexican american families: specific role of diacylglycerols","volume":"62","author":"Kulkarni","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0021817","article-title":"Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide","volume":"6","author":"Spijkers","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diabres.2011.03.017","article-title":"Inhibition of ceramide synthesis reverses endothelial dysfunction and atherosclerosis in streptozotocin-induced diabetic rats","volume":"93","author":"Chun","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib68","doi-asserted-by":"crossref","first-page":"C186","DOI":"10.1152\/ajpcell.00243.2010","article-title":"Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries","volume":"301","author":"Moral-Sanz","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib69","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1161\/01.HYP.33.6.1441","article-title":"Effect of ceramide on K(Ca) channel activity and vascular tone in coronary arteries","volume":"33","author":"Li","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib70","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1194\/jlr.P081281","article-title":"Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients","volume":"59","author":"Anroedh","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib71","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/BJ20050291","article-title":"Mammalian Lass 6 and its related family members regulate synthesis of specific ceramides","volume":"390","author":"Mizutani","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib72","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.M111.280271","article-title":"Eleven residues determine the acyl chain specificity of ceramide synthases","volume":"287","author":"Tidhar","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib73","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1152\/ajpendo.00134.2015","article-title":"Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans","volume":"309","author":"Bergman","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib74","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00125-018-4590-6","article-title":"Ceramide stearic to palmitic acid ratio predicts incident diabetes","volume":"61","author":"Hilvo","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib75","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1007\/s00125-018-4720-1","article-title":"Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study","volume":"61","author":"Neeland","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib76","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/db17-1449","article-title":"Circulating sphingolipids, insulin, HOMA-IR and HOMA-B: the strong heart family study running title: sphingolipids and insulin resistance markers","volume":"67","author":"Lemaitre","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/db08-1228","article-title":"Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance","volume":"58","author":"Haus","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib78","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1515\/jpem-2012-0407","article-title":"Plasma ceramides are elevated in female children and adolescents with type 2 diabetes","volume":"26","author":"Lopez","year":"2013","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib80","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/HCO.0b013e328362059d","article-title":"Recent clinical trials evaluating benefit of drug therapy for modification of HDL cholesterol","volume":"28","author":"Wright","year":"2013","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: geneticanchorsfor causal inference in epidemiological studies","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib82","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurheartj\/eht571","article-title":"Mendelian randomization of blood lipids for coronary heart disease","volume":"36","author":"Holmes","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib83","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/MED.0000000000000230","article-title":"Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future","volume":"23","author":"Burgess","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/jmedgenet-2014-102438","article-title":"Mendelian randomisation applied to drug development in cardiovascular disease: a review","volume":"52","author":"Mokry","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib85","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ije\/dyl114","article-title":"Fibrinogen and coronary heart disease: test of causality by \u201cMendelian randomization","volume":"35","author":"Keavney","year":"2006","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib86","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib87","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11906-011-0242-7","article-title":"Mendelian randomization: application to cardiovascular disease","volume":"14","author":"Timpson","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib88","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib89","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000672","article-title":"Genetic determinants of circulating sphingolipid concentrations in European populations","volume":"5","author":"Hicks","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002490","article-title":"Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations","volume":"8","author":"Demirkan","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib92","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1038\/s41467-019-11954-8","article-title":"Genetic architecture of human plasma lipidome and its link to cardiovascular disease","volume":"10","author":"Tabassum","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib93","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddab002","article-title":"Heritability and family-based GWAS analyses of the N-acyl ethanolamine and ceramide plasma lipidome","author":"McGurk","year":"2021","journal-title":"Hum. Mol. Genet. ddab002"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib94","first-page":"648","article-title":"Lockhart, the Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"384","author":"Ardlie","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib95","first-page":"1121","article-title":"CARDIoGRAMplusC4D Consortium, A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib96","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1194\/jlr.P094433","article-title":"Rare DEGS1 variant significantly alters de novo ceramide synthesis pathway","volume":"60","author":"Blackburn","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib97","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/CIRCGENETICS.114.000600","article-title":"Human plasma lipidome is pleiotropically associated with cardiovascular risk factors and death","volume":"7","author":"Bellis","year":"2014","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib98","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1194\/jlr.RA119000594","article-title":"Heritability of 596 lipid species and genetic correlation with cardiovascular traits in the Busselton Family Heart Study","volume":"61","author":"Cadby","year":"2020","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib99","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58954","article-title":"Genetic and environmental determinants of variation in the plasma lipidome of older australian twins","volume":"9","author":"Wong","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib100","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/hmg\/ddx062","article-title":"Association analyses of East Asian individuals and trans-ancestry analyses with European individuals reveal new loci associated with cholesterol and triglyceride levels","volume":"26","author":"Spracklen","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib101","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib102","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41588-018-0222-9","article-title":"Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program","volume":"50","author":"Klarin","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib103","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ng.3843","article-title":"Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation","volume":"49","author":"Christophersen","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib104","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41588-018-0171-3","article-title":"Biobank-driven genomic discovery yields new insight into atrial fibrillation biology","volume":"50","author":"Nielsen","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib105","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41588-018-0133-9","article-title":"Multi-ethnic genome-wide association study for atrial fibrillation","volume":"50","author":"Roselli","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib106","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jelectrocard.2014.12.010","article-title":"Atrial fibrillation in patients admitted to coronary care units in western Sweden - focus on obesity and lipotoxicity","volume":"48","author":"Gizurarson","year":"2015","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib107","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-020-2263-3","article-title":"Identification of type 2 diabetes loci in 433,540 East Asian individuals","volume":"582","author":"Spracklen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib108","first-page":"1","article-title":"Network-based analysis of the sphingolipid metabolism in hypertension","volume":"5","author":"Fenger","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib109","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","article-title":"Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort","volume":"36","author":"Havulinna","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib110","first-page":"357","article-title":"Ceramide is upregulated and associated with mortality in patients with chronic heart failure","volume":"31","author":"Yu","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib111","first-page":"163","article-title":"Plasma ceramides as prognostic biomarkers and their arterial and myocardial tissue correlates in acute myocardial infarction, JACC basic to transl","volume":"3","author":"de Carvalho","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002383","article-title":"Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis","volume":"14","author":"Wheeler","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib113","doi-asserted-by":"crossref","first-page":"45040","DOI":"10.1038\/srep45040","article-title":"1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function","volume":"7","author":"Gorski","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib114","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41467-018-07867-7","article-title":"Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies","volume":"10","author":"Morris","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib116","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3390\/genes10110945","article-title":"Genome-wide association study of body mass index and body fat in mexican-mestizo children","volume":"10","author":"Costa-Urrutia","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib117","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1161\/HYPERTENSIONAHA.117.09438","article-title":"Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney","volume":"70","author":"Wain","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib118","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ng.3660","article-title":"Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci","volume":"48","author":"Liu","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib119","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ng.3654","article-title":"Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension","volume":"48","author":"Surendran","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2021.04.021_bib120","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/aje\/kwz005","article-title":"Multiancestry genome-wide association study of lipid levels incorporating gene-alcohol interactions","volume":"188","author":"De Vries","year":"2019","journal-title":"Am. J. Epidemiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021002240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021002240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:45:28Z","timestamp":1758156328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021002240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":120,"alternative-id":["S0021915021002240"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.04.021","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}